Jinling Zheng

机构：Suzhou University of Technology, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, Shenzhen Institutes of Advanced Technology, University of Chinese Academy of Sciences, University of South China · ORCID：0000-0001-6602-4548

发表论文 12 篇 · 总被引 224 次 · h-index 6

代表论文

• Development of PI3K inhibitors: Advances in clinical trials and new strategies (Review) (2021 · Pharmacological Research · 被引 72)
• In Situ Activated NK Cell as Bio‐Orthogonal Targeted Live‐Cell Nanocarrier Augmented Solid Tumor Immunotherapy (2022 · Advanced Functional Materials · 被引 64)
• Graphene-based materials: A new tool to fight against breast cancer (2021 · International Journal of Pharmaceutics · 被引 23)
• The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents (2023 · Bioorganic & Medicinal Chemistry · 被引 21)
• Nanobiohybrid Oncolytic Bacteria with Optimized Intratumoral Distribution for Combined Sono–Photodynamic/Immunotherapy (2025 · ACS Nano · 被引 17)
• [Antioxidative effect of constituents of herba Epimedii (ESPS)]. (1997 · PubMed · 被引 10)